Who invested in HepaRegeniX?
HepaRegeniX's investors include Novo Holdings, Wellington Partners, Boehringer Ingelheim Venture Fund, Boehringer Ingelheim and Novo Seeds.

Germany · Venture startup
Funding summaryUpdated 26 Oct 2026
$34Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From HepaRegeniX's own website: 13 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
HepaRegeniX's investors include Novo Holdings, Wellington Partners, Boehringer Ingelheim Venture Fund, Boehringer Ingelheim and Novo Seeds.
HepaRegeniX has raised $34M across 2 rounds since 2017.
HepaRegeniX's most recent round was a Venture of $24M in Apr 2025.
Its most recent round, $24M in Apr 2025, is also its largest on record.
HepaRegeniX's first round on record, in Jan 2017, was backed by Boehringer Ingelheim and Novo Seeds.
HepaRegeniX's latest named round is a Venture, in Apr 2025.
HepaRegeniX is based in Germany.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.